Yeztugo Disease Interactions

There are 2 disease interactions with Yeztugo (lenacapavir).

Moderate

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease

Lenacapavir has not been studied in patients with severe hepatic impairment (Child-Pugh Class C).

Moderate

Moderate Potential Hazard, Moderate plausibility.

Lenacapavir has not been studied in patients with end stage renal disease (estimated creatinine clearance less than 15 mL per minute).

There are 472 drug interactions with Yeztugo (lenacapavir).

QR code containing a link to this page

More about Yeztugo (lenacapavir)

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major	Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate	Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor	Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown	No interaction information available.

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Drug Status

Availability Prescription only Rx

Pregnancy & Lactation Risk data available

CSA Schedule* Not a controlled drug N/A

Approval History Drug history at FDA

User Reviews & Ratings